Ganga Pharmaceuticals Limited (BOM:539680)

Ganga Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	71	49	118	57	42	30
Market Cap Growth	101.92%	-58.34%	108.67%	35.90%	36.67%	6.38%
Enterprise Value	86	60	135	75	59	49
Last Close Price	12.00	10.17	24.41	13.93	10.25	7.50
PE Ratio	109.47	62.24	253.25	143.94	109.87	149.66
PS Ratio	2.63	1.87	4.32	2.19	1.67	1.28
PB Ratio	0.86	0.69	1.67	1.04	0.77	0.57
P/TBV Ratio	0.86	0.69	1.67	1.04	0.77	0.57
EV/Sales Ratio	3.20	2.28	4.94	2.91	2.36	2.07
EV/EBITDA Ratio	-	-	234.37	1591.29	139.49	158.24
EV/EBIT Ratio	-	-	1606.20	-	-	-
EV/FCF Ratio	-9.46	-	-	-	-	-
Debt / Equity Ratio	0.19	0.20	0.19	0.34	0.36	0.32
Debt / EBITDA Ratio	-	-	23.54	386.63	45.76	55.60
Asset Turnover	0.28	0.30	0.33	0.32	0.32	0.31
Inventory Turnover	1.05	1.01	1.03	1.07	1.13	1.15
Quick Ratio	0.68	0.76	0.80	0.49	0.54	0.52
Current Ratio	4.75	4.28	4.81	2.72	2.91	2.86
Return on Equity (ROE)	1.04%	1.11%	0.75%	0.72%	0.70%	0.38%
Return on Assets (ROA)	-0.49%	-1.16%	0.06%	-0.40%	-0.10%	-0.19%
Return on Invested Capital (ROIC)	-0.76%	-1.63%	0.08%	-0.52%	-0.13%	-0.18%
Return on Capital Employed (ROCE)	-0.90%	-2.20%	0.10%	-0.80%	-0.20%	-0.40%
Earnings Yield	1.12%	1.61%	0.40%	0.69%	0.91%	0.67%
FCF Yield	-12.85%	-13.74%	-10.90%	-0.97%	-5.42%	-6.31%
Buyback Yield / Dilution	-4.46%	-	-62.79%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.